術後疼痛に対するリドカイン注入の長期転帰(LOLIPOP)試験 (LOLIPOP)
The LOLIPOP Trial is a large (n=4,300 patients) pragmatic, international, multicentre, prospective, randomised, double blind, placebo-controlled, parallel assessment, safety and effectiveness superiority study.
調査の概要
詳細な説明
The Trial's purpose is to evaluate the effectiveness of lidocaine infusions commenced during surgery and extending up to 24 hours postoperatively, on the incidence of moderate or severe chronic post-surgical pain (CPSP) detected one year following surgery in female patients undergoing elective breast cancer surgery. The trial has 90% power to detect a clinically meaningful (25%) reduction in the incidence of the primary outcome. Secondary outcomes include safety events, analgesic efficacy (pain scores and opioid consumption), neuropathic characteristics of CPSP, and psychological and quality of life outcomes.
研究の種類
入学 (推定)
段階
- フェーズ 3
連絡先と場所
研究連絡先
- 名前:Gillian Ormond
- 電話番号:+610399030387
- メール:gillian.ormond@monash.edu
研究連絡先のバックアップ
- 名前:Natalie Hird
- 電話番号:+61 (0) 459 407 231
- メール:natalie.hird@health.wa.gov.au
研究場所
-
-
-
Belfast、イギリス、BT9 7AB
- 募集
- Belfast City Hospital
-
Bristol、イギリス、BS10 5NB
- 募集
- Southmead Hospital, North Bristol Trust
-
Darlington、イギリス、DL3 6HX
- 終了しました
- Darlington Memorial Hospital
-
Dudley、イギリス、DY1 2HQ
- 募集
- Russells Hall Hospital
-
Liverpool、イギリス
- 募集
- Royal Liverpool and Broadgreen Hospitals
-
London、イギリス、N19 5NF
- 募集
- Whittington Hospital
-
London、イギリス
- 募集
- Royal Marsden Hospital - London and Sutton
-
Newcastle upon Tyne、イギリス
- 募集
- Newcastle upon Tyne Hospitals
-
Norwich、イギリス、NR4 7UY
- 募集
- Norfolk and Norwich University Hospital
-
Rotherham、イギリス、S60 2UD
- 募集
- Rotherham NHS Foundation Trust
-
Sheffield、イギリス、S10 2JF
- 募集
- Royal Hallamshire Hospital
-
Southampton、イギリス
- 募集
- University Hospital Southampton
-
St Helens、イギリス、WA9 3DA
- 募集
- St Helen's Hospital
-
Torquay、イギリス、TQ2 7AA
- 積極的、募集していない
- Torbay Hospital
-
Winchester、イギリス、SO22 5DG
- 募集
- Royal Hampshire County Hospital
-
-
Scotland
-
Wishaw、Scotland、イギリス
- 募集
- University Hospital Wishaw
-
-
-
-
New South Wales
-
Kingswood、New South Wales、オーストラリア、2747
- 募集
- Nepean Hospital
-
Mount Druitt、New South Wales、オーストラリア、2770
- 募集
- Blacktown Mount Druitt Hospital
-
Sydney、New South Wales、オーストラリア、2217
- 募集
- St George Hospital
-
Sydney、New South Wales、オーストラリア、2145
- 完了
- Westmead Hospital
-
Sydney、New South Wales、オーストラリア、2035
- 募集
- Royal North Shore Hospital
-
-
Queensland
-
Brisbane、Queensland、オーストラリア、4029
- 完了
- Royal Brisbane and Women's Hospital
-
Coopers Plains、Queensland、オーストラリア、4108
- 積極的、募集していない
- Queen Elizabeth II Jubilee Hospital
-
Mackay、Queensland、オーストラリア、4740
- 積極的、募集していない
- Mackay Base Hospital
-
Rockhampton、Queensland、オーストラリア、4700
- 完了
- Rockhampton Hospital
-
Southport、Queensland、オーストラリア、4215
- 完了
- Gold Coast Hospital and Health Service- Gold Coast University Hospital
-
Woolloongabba、Queensland、オーストラリア、4102
- 募集
- Princess Alexandra Hospital
-
-
South Australia
-
Bedford Park、South Australia、オーストラリア、5042
- 募集
- Flinders Medical Centre
-
-
Tasmania
-
Hobart、Tasmania、オーストラリア、7000
- 募集
- Royal Hobart Hospital
-
-
Victoria
-
Ballarat、Victoria、オーストラリア、3350
- 完了
- Anaesthetic Group Ballarat
-
Ballarat、Victoria、オーストラリア、3350
- 積極的、募集していない
- Ballarat Health Services (Grampians Health)
-
Geelong、Victoria、オーストラリア、3220
- 募集
- Barwon Health - University Hospital Geelong
-
Melbourne、Victoria、オーストラリア、3065
- 募集
- St Vincent's Hospital Melbourne
-
Melbourne、Victoria、オーストラリア、3004
- 募集
- The Alfred
-
Melbourne、Victoria、オーストラリア、3050
- 積極的、募集していない
- Royal Melbourne Hospital
-
Melbourne、Victoria、オーストラリア、3165
- 完了
- Monash Health - Moorabbin Hospital
-
Melbourne、Victoria、オーストラリア、3076
- 引きこもった
- Northern Hospital
-
Ringwood East、Victoria、オーストラリア、3135
- 募集
- Maroondah Hospital - Eastern Health
-
Shepparton、Victoria、オーストラリア、3630
- 完了
- Goulburn Valley Health
-
Traralgon、Victoria、オーストラリア、3844
- 引きこもった
- Latrobe Regional Hospital
-
-
Western Australia
-
Bentley、Western Australia、オーストラリア、6102
- 募集
- Bentley Health Service
-
Perth、Western Australia、オーストラリア、6000
- 募集
- Royal Perth Hospital
-
Perth、Western Australia、オーストラリア、6008
- 募集
- St John of God Subiaco
-
-
-
-
Auckland
-
Auckland、Auckland、ニュージーランド、1023
- 募集
- Auckland City Hospital
-
-
Middlemore
-
Auckland、Middlemore、ニュージーランド、2025
- 募集
- Middlemore Hospital
-
-
Waikato Region
-
Hamilton、Waikato Region、ニュージーランド、3204
- 募集
- Waikato Hospital
-
-
-
-
-
Chai Wan、香港
- 募集
- Pamela Youde Nethersole Eastern Hospital
-
Wan Chai、香港
- 募集
- Ruttonjee Hospital
-
-
Sha Tin
-
Shatin、Sha Tin、香港
- 募集
- North District Hospital
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
- Consenting adult female patients (≥18 years) undergoing mastectomy (unilateral or bilateral) or breast conserving surgery (unilateral or bilateral) for the primary excision of confirmed or suspected primary breast cancer under general anaesthesia (including those with simultaneous insertion of tissue expanders or implants)*. * this specifically excludes patients undergoing surgery for locoregional recurrence
- American Society of Anaesthesiologist (ASA) physical scale 1-3
Exclusion Criteria:
- Mastectomy or breast conserving surgery with add on procedures e.g laparoscopic salpingectomy
- Where surgery is being performed for locoregional recurrence of breast cancer
- Pre-existing pain at site of surgery, axilla, ipsilateral side of chest wall or the ipsilateral upper arm (at diagnosis prior to any tumor locating procedures)
- Re-excision procedures where the margins at the index surgery have been deemed insufficient
- When immediate autologous reconstruction surgery is planned
- Where delayed autologous reconstruction surgery on the operative breast within one year is planned
- Planned use of regional analgesia infusions
- Impaired cognition
- Pregnant or lactating females
- Transgender patients
- Known metastatic disease
- History of anaphylaxis, sensitivity or known contraindication to lidocaine (or other amide local anaesthetic agents e.g. other amide local anaesthetic agents: ropivacaine, bupivacaine, mepivacaine, prilocaine, etidocaine), including patients with porphyria or methaemoglobinaemia
- History of epilepsy
- Baseline heart rate < 50 bpm or systolic blood pressure < 100mmHg.
- Acute coronary event in the last three months
- Cardiac conduction abnormalities, including; Atrial fibrillation, Heart block (all degrees), Bundle Branch Block or Fascicular block, Prolonged QT interval, Wolf Parkinson White syndrome, channelopathy such as Brugada syndrome. A preoperative Electrocardiogram (ECG) is not mandatory, unless clinically indicated
- Abnormal serum potassium concentration (based upon site laboratory reference ranges)
- Active liver disease e.g. viral hepatitis, alcoholic liver disease, non-alcoholic fatty liver disease, haemochromatosis, other rarer causes)
- Medications within the last 7 days which are known / suspected to slow lidocaine metabolism (amiodarone, beta blockers, cimetidine, fluoroquinolones, fluvoxamine, imidazoles, macrolides, verapamil, HIV drugs)
- Cardiac Failure (any documented heart failure at peroperative assessment or GP records)
- Severe Renal Failure (Creatinine Clearance of less than 30ml/min or dialysis dependent)
- Co-administration of lidocaine within 24 hours prior to surgery for other reasons (e.g. lidocaine patches
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:防止
- 割り当て:ランダム化
- 介入モデル:並列代入
- マスキング:4倍
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
アクティブコンパレータ:Lidocaine
2% Lidocaine infusion intra-operative and 10% Lidocaine infusion post-operative. |
Lidocaine infusion:
他の名前:
|
|
プラセボコンパレーター:Placebo
0.9% Saline infusion intra-operative and 0.9% Saline infusion post-operative. |
Placebo infusion:
他の名前:
|
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
The incidence of moderate or severe CPSP at 1 year after surgery, as reported by the patient at the follow-up review.
時間枠:1 year post-surgery
|
Numerical rating scale ≥4 out of 10 for worst pain in the last week - The pain must have been present for at least 3 months prior to the one year assessment (or longer). |
1 year post-surgery
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
The incidence of severe CPSP at 1 year after surgery
時間枠:1 year post surgery
|
NRS for worst pain the in the last week of ≥7) |
1 year post surgery
|
|
Severity of pain at the site of surgery
時間枠:1 year post surgery
|
Assessed using "average" and "worst" NRS pain score in the last week, obtained from the adapted modified Brief Pain Inventory-Short Form (mBPI-SF) |
1 year post surgery
|
|
Incidence of neuropathic symptoms
時間枠:1 year post surgery
|
Incidence examined as a binary outcome using the Short Form of Douleur Neuropathique 4 Questions (S-DN4) |
1 year post surgery
|
|
Physical functioning
時間枠:1 year post surgery
|
Using interference component of mBPI-SF |
1 year post surgery
|
|
Changes in quality of life metrics EuroQol 5 Dimension 5 Level (EQ-5D-5L) at 1 year after surgery compared to baseline
時間枠:1 year post surgery
|
Changes in the quality of life |
1 year post surgery
|
|
Changes in psychological wellbeing Kessler Psychological Distress Scale (K-10) at 1 year after surgery compared to baseline.
時間枠:1 year post surgery
|
Changes in psychological wellbeing |
1 year post surgery
|
|
The incidence of mild or greater pain at the site of surgery at 1 year after surgery
時間枠:1 year post surgery
|
NRS for worst pain the in the last week of ≥1 |
1 year post surgery
|
|
The incidence of discomfort or altered sensation at the site of surgery (not reported as pain)
時間枠:1 year post surgery
|
Patients asked if they have any altered sensation at the site of surgery |
1 year post surgery
|
|
Severity of acute postoperative pain at rest
時間枠:24 hours postoperatively
|
Maximum pain score, Numerical rating scale (NRS) 0-10 |
24 hours postoperatively
|
|
Severity of Acute postoperative pain on movement
時間枠:24 hours postoperatively
|
Maximum pain score, Numerical rating scale (NRS) 0-10 |
24 hours postoperatively
|
|
Postoperative opioid consumption
時間枠:on Day 1
|
Morphine Equivalent Opioid Consumption (MEQ) |
on Day 1
|
|
Postoperative opioid consumption
時間枠:3 months (last 24-hours)
|
Morphine Equivalent Opioid Consumption (MEQ) |
3 months (last 24-hours)
|
|
Postoperative opioid consumption
時間枠:1 year post surgery (last 24 hours)
|
Morphine Equivalent Opioid Consumption (MEQ) |
1 year post surgery (last 24 hours)
|
|
The incidence of mortality at 1 year
時間枠:1 year post surgery
|
Mortality at 1 year |
1 year post surgery
|
|
UK NHS costs of care over 1 year following surgery
時間枠:1 year post surgery
|
UK/NHS sites only |
1 year post surgery
|
|
Productivity costs over 1 year following surgery
時間枠:1 year post surgery
|
UK/NHS sites only |
1 year post surgery
|
|
Quality-adjusted life years (QALYs) over 1 year following surgery
時間枠:1 year post surgery
|
UK/NHS sites only |
1 year post surgery
|
|
Cost-effectiveness of perioperative lidocaine infusions compared to usual care, from a primary UK NHS perspective and broader perspective including productivity, at 1 year.
時間枠:1 year post surgery
|
UK/NHS sites only |
1 year post surgery
|
その他の成果指標
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Incidence of treated bradycardia intraoperatively
時間枠:24 hours postoperatively
|
Drug related safety Endpoints |
24 hours postoperatively
|
|
Incidence of treated hypotension intraoperatively
時間枠:24 hours postoperatively
|
Drug related safety Endpoints |
24 hours postoperatively
|
|
Incidence of treated bradycardia in Post Anaesthesia Care Unit (PACU)
時間枠:24 hours postoperatively
|
Drug related safety Endpoints |
24 hours postoperatively
|
|
Incidence of treated hypotension in Post Anaesthesia Care Unit (PACU)
時間枠:24 hours postoperatively
|
Drug related safety Endpoints |
24 hours postoperatively
|
|
Incidence of intraoperative infusion stopping events
時間枠:24 hours postoperatively
|
Drug related safety Endpoints |
24 hours postoperatively
|
|
Incidence of Post Anaesthesia Care Unit (PACU) infusion stopping events
時間枠:24 hours postoperatively
|
Drug related safety Endpoints, (x2 symptoms, x1 sign, x1 complication) |
24 hours postoperatively
|
|
Incidence of postoperative infusion stopping events on the ward
時間枠:24 hours postoperatively
|
Drug related safety Endpoints, (x2 symptoms, x1 sign, x1 complication) |
24 hours postoperatively
|
|
Incidence of suspected lidocaine toxicity events
時間枠:24 hours postoperatively
|
Drug related safety Endpoints |
24 hours postoperatively
|
|
Incidence of suspected SEVERE lidocaine toxicity events
時間枠:24 hours postoperatively
|
Drug related safety Endpoints, (generalised seizure, sudden unexplained LOC, life-threatening arrhythmia, or asystole, cardiac or circulatory arrest) |
24 hours postoperatively
|
|
Incidence of Medical Emergency Team (MET) activation
時間枠:24 hours postoperatively
|
Drug related safety Endpoints |
24 hours postoperatively
|
|
Incidence of unplanned Intensive Care Unit (ICU), High Dependency Unit (HDU) or Critical Care Unit (CCU) admission
時間枠:24 hours postoperatively
|
Drug related safety Endpoints |
24 hours postoperatively
|
|
Incidence of study drug unblinding events
時間枠:24 hours postoperatively
|
Drug related safety Endpoints |
24 hours postoperatively
|
|
Incidence of subcutaneous catheter site events
時間枠:Day 30
|
Drug related safety Endpoints |
Day 30
|
協力者と研究者
出版物と役立つリンク
一般刊行物
- Toner AJ, Bailey MA, Schug SA, Corcoran TB. A pilot multicentre randomised controlled trial of lidocaine infusion in women undergoing breast cancer surgery. Anaesthesia. 2021 Oct;76(10):1326-1341. doi: 10.1111/anae.15440. Epub 2021 Mar 2.
- Toner AJ, Bailey MA, Schug SA, Phillips M, Ungerer JP, Somogyi AA, Corcoran TB. Serum lidocaine (lignocaine) concentrations during prolonged perioperative infusion in patients undergoing breast cancer surgery: A secondary analysis of a randomised controlled trial. Anaesth Intensive Care. 2023 Nov;51(6):422-431. doi: 10.1177/0310057X231194833. Epub 2023 Oct 6.
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (推定)
研究の完了 (推定)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
追加の関連 MeSH 用語
その他の研究ID番号
- HREC/74777/Alfred-2021
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
米国で製造され、米国から輸出された製品。
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。